Biomedical subjects

C P Vartan

Publications and source records attributed to C P Vartan.

3 recordsLinked to original sources

PubMed1977

Upper gastrointestinal endoscopy--a GP service.

Since 1974 there has been an open endoscopy service available to general practitioners in the Bournemouth and Christchurch area. Patients are referred directly with a standard form. A retrospective comparison of requests for barium-meal examinations and for endoscopy by general practitioners showed that the reasons for referral were similar. Forty per cent of patients in each group showed no abnormality. Ulceration was found in 21.1% of patients who underwent endoscopy and 9.7% investigated by barium meal. Duodenitis or gastric erosions were found in a further 16% of endoscopies. More hiatus hernias and deformed duodenal caps were found at barium meal. Despite these differences the results of follow-up were similar.

Adult↗

PubMed1970

Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.

Cytosine arabinoside and daunorubicin used in an intensive intermittent regimen have been shown to be an effective combination for the induction of complete remissions in 14 out of 23 adult patients with acute myelogenous leukaemia. This gives an overall complete remission rate of 60%. A further patient had a good partial remission. The addition of L-asparaginase to the regimen has not increased the incidence of remission and there were more side effects in the L-asparaginasetreated group. Of the 10 patients treated with L-asparaginase in addition to cytosine arabinoside and daunorubicin, five achieved a complete remission. Of the 13 patients treated with cytosine arabinoside and daunorubicin without L-asparaginase, nine achieved a complete remission and one a good partial remission.

Adolescent↗

PubMed1970

Combination chemotherapy in generalized Hodgkin's disease.

Fifty-two patients with generalized Hodgkin's disease were treated with a combination of mustine hydrochloride, vinblastine, procarbazine, and prednisolone. Complete remissions were obtained initially in six out of seven patients (86%) who had previously received no treatment, in 15 out of 19 (79%) who had had only radiotherapy in the past, and in 9 out of 26 (35%) who had previously been given chemotherapy with or without radiotherapy. Of these 30 patients in whom a complete remission was obtained 22 have been free of any symptoms or signs of disease for periods ranging from 4 to 22 months. The response to treatment was rapid, and toxicity was not a major problem, except in those who had previously been treated with cytotoxic drugs used continuously and not in courses. A comparative trial of radiotherapy and combination therapy in the treatment of Stage III Hodgkin's disease is strongly recommended.

Antimetabolites↗